14.12.2018
- US biopharma AVEO Oncology is collaborating with Anglo-Swedish drug major AstraZeneca on a combined treatment for liver cancer. The partners will evaluate the safety and efficacy...
19.08.2015
- US biopharmaceutical company Aveo Oncology has entered into a global license agreement with Novartis for its AV-380 and related antibodies. AV-380 is a potent inhibitory antibody...